Meeting
2016 ASCO Annual Meeting
Comparison between circulating tumor DNA and tumor tissue multiple gene detection in non-small cell lung cancer patients by targeted sequencing with the Ion PGM and AmpliSeq Cancer Panel.
Authors
Fan Yang
Peking University People's Hospital, Beijing, China
Fan Yang , Kezhong Chen , Feng Lou , Jingbo Zhang , Hua Ye , Wei Chen , Tian Guan , Mingyu Zhao , Xuexia Su , Rong Shi , Si-Yi Chen , Jun Wang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Local-Regional Non–Small Cell Lung Cancer
Citation
J Clin Oncol 34, 2016 (suppl; abstr 8544)
DOI
10.1200/JCO.2016.34.15_suppl.8544
Abstract #
8544
Poster Bd #
172
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Targeted ctDNA sequencing analysis reveals concurrent genomic alterations and its impact on TKI and immune checkpoint inhibitor therapy in advanced NSCLC from Asian population.
First Author: Wei Wu
Poster
2019 Breakthrough
Plasma circulating tumor DNA-based genetic profiling of lung cancer patients in Vietnam using ultra-deep massive parallel sequencing with unique identifier tagging.
First Author: Huy Phuoc Do
Poster
2019 Breakthrough
An optimized ultra-deep massively parallel sequencing with unique molecular identifier tagging for detection and quantification of circulating tumor DNA from lung cancer patients.
First Author: Hong-Anh Thi Pham
Poster
2024 ASCO Annual Meeting
Characterization of diverse targetable ERBB2 alterations in 512,993 patients with solid tumors.
First Author: Dazhi Liu